# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Johnny Cash (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML004-SYN-TD
- Date: 2003-02-27
- Fictional facility: St. Posthumous Health Center
- Fictional author: Gideon Hale, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Subjective

The patient participates in this fictional visit for primary care new-patient visit for diabetes, lightheadedness on standing, and glaucoma follow-up. **S**

## Objective

HbA1c: 8.6% (high); Sodium: 138 mmol/L; Potassium: 4.4 mmol/L; Creatinine: 1.04 mg/dL; eGFR: 74 mL/min/1.73 m²; Glucose: 186 mg/dL (high); LDL cholesterol: 128 mg/dL (high); Urine albumin-creatinine ratio: 18 mg/g; ALT: 24 U/L; AST: 22 U/L; Vitamin B12: 286 pg/mL; TSH: 1.9 mIU/L; Hemoglobin: 13.8 g/dL; Intraocular pressure, right eye: 22 mmHg (high); Intraocular pressure, left eye: 24 mmHg (high); Mean RNFL thickness by OCT, right eye: 61 um (low); Mean RNFL thickness by OCT, left eye: 57 um (low); Best-corrected visual acuity, right eye (ETDRS letters): 68 (low); Best-corrected visual acuity, left eye (ETDRS letters): 63 (low); PHQ-2: 1; Mini-Cog: 5. All results are synthetic.

BP 146/80 mmHg; pulse 78 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 95% on room air; weight 96 kg; BMI 27.2 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Type 2 diabetes mellitus with diabetic autonomic neuropathy; HbA1c above the individualized goal at intake; Neurogenic orthostatic hypotension from diabetic autonomic neuropathy; Diabetic distal symmetric polyneuropathy with loss of protective sensation in both feet; Primary open-angle glaucoma, both eyes, severe stage; Mild nonproliferative diabetic retinopathy without macular edema, both eyes; Hyperlipidemia; History of recurrent pneumonia. Strengths and supports remain part of the care plan. **S**

## Medication changes

- Stopped: Metformin 500 mg oral tablet, one tablet by mouth twice daily with meals **S**
- Started: Metformin 1000 mg oral tablet, one tablet by mouth twice daily with meals **S**
- Started: Atorvastatin 40 mg oral tablet, one tablet by mouth daily **S**
- Continued without change: Latanoprost 0.005% ophthalmic solution, one drop in each eye at bedtime **S**
- Started: Dorzolamide 2% ophthalmic solution, one drop in each eye twice daily **S**

## Plan

- Increase metformin to 1000 mg twice daily and set an individualized HbA1c goal below 7.5%; avoid insulin and sulfonylureas while autonomic neuropathy may blunt warning symptoms of hypoglycemia. Guideline: Standards of Care in Diabetes—2025 (2025); CMID: Clinical Monitoring Intelligence Database, diabetes, glaucoma, and hyperlipidemia monographs (2026) **S**
- Endocrinology consultation to confirm diabetic autonomic neuropathy as the cause of orthostatic hypotension, reconsider the earlier Shy-Drager label, and choose add-on glucose-lowering therapy. Guideline: Standards of Care in Diabetes—2025 (2025) **S**
- Treat neurogenic orthostatic hypotension: stand up in stages, raise the head of the bed, use waist-high compression, drink 2 liters of fluid a day, then midodrine with the last dose at least four hours before bed; check supine blood pressure at each visit. Guideline: Standards of Care in Diabetes—2025 (2025) **S**
- Check HbA1c every three months until at goal, a basic metabolic panel, UACR, and lipids each year, lipids 4 to 12 weeks after starting a statin, and vitamin B12 periodically on metformin. Guideline: Standards of Care in Diabetes—2025 (2025); CMID: Clinical Monitoring Intelligence Database, diabetes, glaucoma, and hyperlipidemia monographs (2026) **S**
- Examine the feet at every visit because of sensory loss; daily self-inspection and protective footwear. Guideline: Standards of Care in Diabetes—2025 (2025); CMID: Clinical Monitoring Intelligence Database, diabetes, glaucoma, and hyperlipidemia monographs (2026) **S**
- Coordinate glaucoma care with the eye clinic: add dorzolamide to latanoprost, check pressure at each visit, and repeat OCT and visual fields every six months; avoid timolol and brimonidine because of bradycardia, bronchospasm, and low blood pressure. Guideline: Primary Open-Angle Glaucoma Preferred Practice Pattern (2025); CMID: Clinical Monitoring Intelligence Database, diabetes, glaucoma, and hyperlipidemia monographs (2026) **S**
- Annual dilated eye examination for diabetic retinopathy; low-vision rehabilitation and home lighting review. Guideline: Standards of Care in Diabetes—2025 (2025); Primary Open-Angle Glaucoma Preferred Practice Pattern (2025) **S**
- Start atorvastatin 40 mg; give PCV20 and recombinant zoster vaccines. Guideline: Standards of Care in Diabetes—2025 (2025) **S**
